Jobes, David A. – Trademark Portfolio
Entity Type: 01
Jobes, David A. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include CAMS-4TEENS, CAMS FRAMEWORK, CAMS TREATMENT, and CAMS ASSESSMENT. The owner is based in Bethesda, MD.
5712 Kingswood Road
Bethesda, MD 20814
Showing of trademarks Trademarks
Trademark Classifications
Jobes, David A.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Jobes, David A. have?
Jobes, David A. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.
What trademark classes does Jobes, David A. file in?
Jobes, David A. files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 16 (Paper Goods). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Jobes, David A.'s most well-known trademarks?
Jobes, David A.'s registered trademark portfolio includes well-known marks such as CAMS-4TEENS, CAMS FRAMEWORK, CAMS TREATMENT, and CAMS ASSESSMENT. These are among 4 currently registered trademarks in the portfolio.
What is Jobes, David A.'s trademark registration success rate?
Jobes, David A. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.